Silverback Therapeutics Inc (SPRY) Insider Trading
- $40,545,225.66
- $38,832,251.45
- Dec. 4, 2024
- Richard E Lowenthal
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 4, 2024 | Director | 14,772 | $13.75 | Sell | $203,115.00 | |
Dec. 3, 2024 | Insider | 45,000 | $13.19 | Sell | $593,550.00 | |
Dec. 2, 2024 | Director | 97,244 | $13.56 | Sell | $1,318,628.64 | |
Nov. 27, 2024 | Insider | 25,000 | $14.39 | Sell | $359,750.00 | |
Nov. 25, 2024 | Insider | 32,814 | $14.00 | Sell | $459,396.00 | |
Nov. 11, 2024 | Major Shareholder | 528,456 | $18.04 | Sell | $9,533,346.24 | |
Oct. 16, 2024 | CFO | 12,500 | $16.00 | Sell | $200,000.00 | |
Oct. 15, 2024 | Insider | 100,000 | $14.88 | Sell | $1,488,000.00 | |
Oct. 8, 2024 | CEO | 100,000 | $13.83 | Sell | $1,383,000.00 | |
Sept. 18, 2024 | Insider | 10,000 | $14.00 | Sell | $140,000.00 | |
Sept. 17, 2024 | CEO | 100,000 | $12.93 | Sell | $1,293,000.00 | |
Aug. 26, 2024 | Director | 83,695 | $13.00 | Sell | $1,088,035.00 | |
Aug. 23, 2024 | Director | 69,500 | $13.03 | Sell | $905,585.00 | |
Aug. 21, 2024 | Director | 407,700 | $13.56 | Sell | $5,528,412.00 | |
Aug. 20, 2024 | COO | 50,000 | $15.00 | Sell | $750,000.00 | |
Aug. 20, 2024 | CFO | 12,500 | $16.00 | Sell | $200,000.00 | |
Aug. 20, 2024 | CEO | 100,000 | $15.03 | Sell | $1,503,000.00 | |
Aug. 19, 2024 | Insider | 10,000 | $14.00 | Sell | $140,000.00 | |
July 16, 2024 | CEO | 100,000 | $11.40 | Sell | $1,140,000.00 | |
July 9, 2024 | Insider | 100,000 | $9.62 | Sell | $962,000.00 | |
June 12, 2024 | Insider | 95,862 | $9.15 | Sell | $877,137.30 | |
June 11, 2024 | CEO | 4,138 | $9.00 | Sell | $37,242.00 | |
May 16, 2024 | Insider | 89,096 | $9.06 | Sell | $807,209.76 | |
May 15, 2024 | CEO | 5,147 | $9.05 | Sell | $46,580.35 | |
May 14, 2024 | Insider | 5,757 | $9.01 | Sell | $51,870.57 | |
May 7, 2024 | Insider | 100,000 | $9.34 | Sell | $934,000.00 | |
April 16, 2024 | Insider | 100,000 | $9.28 | Sell | $928,000.00 | |
April 9, 2024 | CEO | 100,000 | $9.28 | Sell | $928,000.00 | |
March 27, 2024 | Director | 505,954 | $9.79 | Buy | $4,953,289.66 | |
March 25, 2024 | Director | 437,600 | $9.06 | Buy | $3,964,656.00 | |
March 25, 2024 | CEO | 95,267 | $9.12 | Sell | $868,835.04 | |
March 22, 2024 | Insider | 2,343 | $9.02 | Sell | $21,133.86 | |
March 21, 2024 | CEO | 472 | $9.00 | Sell | $4,248.00 | |
March 19, 2024 | CEO | 1,918 | $9.03 | Sell | $17,319.54 | |
March 15, 2024 | CEO | 96,756 | $9.14 | Sell | $884,349.84 | |
March 14, 2024 | Insider | 444 | $9.00 | Sell | $3,996.00 | |
March 13, 2024 | CEO | 2,800 | $9.00 | Sell | $25,200.00 | |
Feb. 29, 2024 | CEO | 3,782 | $9.02 | Sell | $34,113.64 | |
Feb. 28, 2024 | Insider | 98,778 | $9.02 | Sell | $890,977.56 | |
Feb. 26, 2024 | Insider | 700 | $9.01 | Sell | $6,307.00 | |
Sept. 28, 2023 | Insider | 40,000 | $3.62 | Buy | $144,800.00 | |
Sept. 21, 2023 | Director | 2,700,000 | $3.03 | Buy | $8,181,000.00 | |
Sept. 1, 2023 | Director | 100,000 | $7.71 | Sell | $771,000.00 | |
Aug. 29, 2023 | Director | 3,750,000 | $6.20 | Buy | $23,250,000.00 | |
Aug. 4, 2023 | Director | 18,897 | $7.06 | Sell | $133,412.82 | |
Aug. 2, 2023 | Director | 36,281 | $7.09 | Sell | $257,232.29 | |
July 6, 2023 | Director | 33,510 | $6.34 | Sell | $212,453.40 | |
July 3, 2023 | Director | 26,520 | $6.72 | Sell | $178,214.40 | |
June 1, 2023 | Director | 73,059 | $6.80 | Sell | $496,801.20 | |
May 9, 2023 | Director | 42,900 | $5.31 | Sell | $227,799.00 |
Insiders are both buying and selling Silverback Therapeutics Inc stock.
The insider traders at Silverback Therapeutics Inc are: Richard E Lowenthal, Sarina Tanimoto, Laura Shawver, Ra Capital Management, L.P., Kathleen D Scott, Justin Chakma, Peter A Thompson, Eric Karas, Brian Dorsey, James E Flynn, and Alexander A Fitzpatrick
The most active insider trader at Silverback Therapeutics Inc is Richard E Lowenthal with 13 trades.
James E Flynn has sold the most Silverback Therapeutics Inc stock with a total value of $19,066,692.48.
Ra Capital Management, L.P. has bought the most Silverback Therapeutics Inc stock with a total value of $45,302,235.32.
The most recent insider trade for Silverback Therapeutics Inc was on Dec. 4, 2024.
The single biggest insider buy for Silverback Therapeutics Inc was from Ra Capital Management, L.P. with a total value of $23,250,000.00 on Aug. 29, 2023.
The single biggest insider sell for Silverback Therapeutics Inc was from James E Flynn with a total value of $9,533,346.24 on Nov. 11, 2024.